Issue navigation
Volume 5, Issue suppl_B, January 1984
PART 1: PATHOPHYSIOLOGY OF ARRHYTHMIAS
Electrophysiology for the clinician
J. T. Bigger
European Heart Journal, Volume 5, Issue suppl_B, January 1984, Pages 1–9, https://doi.org/10.1093/eurheartj/5.suppl_B.1
Mechanisms contributing to arrhythmias during ischaemia and infarction
J. B. Kramer and P. B. Corr
European Heart Journal, Volume 5, Issue suppl_B, January 1984, Pages 11–18, https://doi.org/10.1093/eurheartj/5.suppl_B.11
Pathophysiology of re-entrant dysrhythmias
S. B. Olsson
European Heart Journal, Volume 5, Issue suppl_B, January 1984, Pages 19–23, https://doi.org/10.1093/eurheartj/5.suppl_B.19
PART 2: DETECTION AND INVESTIGATION OF ARRHYTHMIAS
Long-term ambulatory ECR-monitoring in the prediction of sudden coronary death
P. R. Lichtlen and others
European Heart Journal, Volume 5, Issue suppl_B, January 1984, Pages 25–30, https://doi.org/10.1093/eurheartj/5.suppl_B.25
Automatic analysis of ambulatory ECG records
R. W. F. Campbell and others
European Heart Journal, Volume 5, Issue suppl_B, January 1984, Pages 31–34, https://doi.org/10.1093/eurheartj/5.suppl_B.31
Induced arrhythmias in clinical decision making
G. Breithardt and M. Borggrefe
European Heart Journal, Volume 5, Issue suppl_B, January 1984, Pages 35–42, https://doi.org/10.1093/eurheartj/5.suppl_B.35
PART 3: PROBLEMS IN CURRENT TREATMENT OF ARRHYTHMIAS
Cardiac arrhythmias in infancy: Prevalence, significance and need for treatment
P. J. Schwartz and P. Salice
European Heart Journal, Volume 5, Issue suppl_B, January 1984, Pages 43–50, https://doi.org/10.1093/eurheartj/5.suppl_B.43
Problems in the treatment of re-entrant arrhythmias: General considerations
P. Brugada and H. J. J. Wellens
European Heart Journal, Volume 5, Issue suppl_B, January 1984, Pages 51–57, https://doi.org/10.1093/eurheartj/5.suppl_B.51
Pharmacology of antiarrythmic drugs for the clinician – Medical emergencies and chronic treatment
L. Storstein
European Heart Journal, Volume 5, Issue suppl_B, January 1984, Pages 59–62, https://doi.org/10.1093/eurheartj/5.suppl_B.59
PART 4: NEWLY DEVELOPED ANTIARRHYTHMIC DRUGS
The clinical pharmacology of lidocaine congeners – Review of encainide, flecainide, lorcainide and tocainide
D. G. McDevitt
European Heart Journal, Volume 5, Issue suppl_B, January 1984, Pages 63–66, https://doi.org/10.1093/eurheartj/5.suppl_B.63
Haemodynamic effects of encainide, flecainide, lorcainide and tocainide
G. Vanhaleweyk and others
European Heart Journal, Volume 5, Issue suppl_B, January 1984, Pages 67–74, https://doi.org/10.1093/eurheartj/5.suppl_B.67
Cardiac electrophysiology of four new antiarrhythmic drugs – encainide, flecainide, lorcainide and tocainide
A. J. Camm
European Heart Journal, Volume 5, Issue suppl_B, January 1984, Pages 75–79, https://doi.org/10.1093/eurheartj/5.suppl_B.75
The use of tocainide, encainide, lorcainide and flecainide for supraventricular arrhythmias
O.M. Orning
European Heart Journal, Volume 5, Issue suppl_B, January 1984, Pages 81–86, https://doi.org/10.1093/eurheartj/5.suppl_B.81
Comparison of the efficacy of newly developed antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias
K. J. Hellestrand
European Heart Journal, Volume 5, Issue suppl_B, January 1984, Pages 87–94, https://doi.org/10.1093/eurheartj/5.suppl_B.87
PART 5: HORIZONS OF ANTIARRHYTHMIC TREATMENT
Pre- and in-hospital antiarrhythmic prevention of ventricular fibrillation complicating acute myocardial infarction
K. I. Lie
European Heart Journal, Volume 5, Issue suppl_B, January 1984, Pages 95–97, https://doi.org/10.1093/eurheartj/5.suppl_B.95
Can chronic antidysrhythmic treatment prevent sudden death?
L. M. Friedman
European Heart Journal, Volume 5, Issue suppl_B, January 1984, Pages 99–101, https://doi.org/10.1093/eurheartj/5.suppl_B.99
Medical versus surgical treatment of tachydysrhythmias
H. L. Waxman and others
European Heart Journal, Volume 5, Issue suppl_B, January 1984, Pages 103–108, https://doi.org/10.1093/eurheartj/5.suppl_B.103
Secondary preventive trials with antiarrhythmic agents: Are we asking the right question?
J. Lubsen
European Heart Journal, Volume 5, Issue suppl_B, January 1984, Pages 109–111, https://doi.org/10.1093/eurheartj/5.suppl_B.109
ABSTRACTS OF POSTER PRESENTATIONS
Abstracts of poster presentations
European Heart Journal, Volume 5, Issue suppl_B, January 1984, Pages 113–137, https://doi.org/10.1093/eurheartj/5.suppl_B.113
DRUG THERAPY IN CARDIOLOGY
Drug Therapy in Cardiology
European Heart Journal, Volume 5, Issue suppl_B, January 1984, Page ii, https://doi.org/10.1093/eurheartj/5.suppl_B.ii
PREFACE
Preface
Stanely H. Taylor and Liv Storstein
European Heart Journal, Volume 5, Issue suppl_B, January 1984, Page iii, https://doi.org/10.1093/eurheartj/5.suppl_B.iii
LIST OF CONTRIBUTORS
List of contributors
European Heart Journal, Volume 5, Issue suppl_B, January 1984, Pages v–vii, https://doi.org/10.1093/eurheartj/5.suppl_B.v
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals